These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes. Goyal BR, Solanki N, Goyal RK, Mehta AA. J Cardiovasc Pharmacol; 2009 Dec; 54(6):502-9. PubMed ID: 19738487 [Abstract] [Full Text] [Related]
3. Effect of spironolactone on cardiovascular complications associated with type-2 diabetes in rats. Patel BM, Kakadiya J, Goyal RK, Mehta AA. Exp Clin Endocrinol Diabetes; 2013 Aug; 121(8):441-7. PubMed ID: 24026828 [Abstract] [Full Text] [Related]
4. Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats. Goyal BR, Parmar K, Goyal RK, Mehta AA. Pharmacol Rep; 2011 Aug; 63(4):956-66. PubMed ID: 22001983 [Abstract] [Full Text] [Related]
10. Occurrence of oxidative impairments, response of antioxidant defences and associated biochemical perturbations in male reproductive milieu in the Streptozotocin-diabetic rat. Shrilatha B, Muralidhara. Int J Androl; 2007 Dec; 30(6):508-18. PubMed ID: 17573857 [Abstract] [Full Text] [Related]
11. Impaired redox signaling and mitochondrial uncoupling contributes vascular inflammation and cardiac dysfunction in type 1 diabetes: Protective role of arjunolic acid. Manna P, Sil PC. Biochimie; 2012 Mar; 94(3):786-97. PubMed ID: 22155371 [Abstract] [Full Text] [Related]
12. Protective effects of nanostructures of hydrated C(60) fullerene on reproductive function in streptozotocin-diabetic male rats. Bal R, Türk G, Tuzcu M, Yilmaz O, Ozercan I, Kuloglu T, Gür S, Nedzvetsky VS, Tykhomyrov AA, Andrievsky GV, Baydas G, Naziroglu M. Toxicology; 2011 Apr 11; 282(3):69-81. PubMed ID: 21163323 [Abstract] [Full Text] [Related]
15. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension. Hakim ZS, Goyal RK. Indian J Physiol Pharmacol; 2000 Apr 11; 44(2):125-35. PubMed ID: 10846625 [Abstract] [Full Text] [Related]
16. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. Soetikno V, Sari FR, Sukumaran V, Lakshmanan AP, Mito S, Harima M, Thandavarayan RA, Suzuki K, Nagata M, Takagi R, Watanabe K. Eur J Pharm Sci; 2012 Oct 09; 47(3):604-14. PubMed ID: 22564708 [Abstract] [Full Text] [Related]
17. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats. Ceylan-Isik A, Hünkar T, Aşan E, Kaymaz F, Ari N, Söylemezoğlu T, Renda N, Soncul H, Bali M, Karasu C, (Antioxidants in Diabetes-Induced Complications) The ADIC Study Group. J Pharm Pharmacol; 2007 Dec 09; 59(12):1629-41. PubMed ID: 18053324 [Abstract] [Full Text] [Related]
18. Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes. Erensoy N, Yilmazer S, Oztürk M, Tunçdemir M, Uysal O, Hatemi H. Acta Histochem; 2004 Dec 09; 106(4):279-87. PubMed ID: 15350810 [Abstract] [Full Text] [Related]
20. Comparative effects of zinc, selenium and vitamin E or their combination on carbohydrate metabolizing enzymes and oxidative stress in streptozotocin induced-diabetic rats. Aly HF, Mantawy MM. Eur Rev Med Pharmacol Sci; 2012 Jan 09; 16(1):66-78. PubMed ID: 22338550 [Abstract] [Full Text] [Related] Page: [Next] [New Search]